Marc Hodroff, MD
Urology · Portland, MENPI 1174560221
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,920 of the $16,714 with a category attached, or 71.3%. Axonics, Inc. accounts for 93.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $13,881 and has fallen 97.1% since, to $400 in 2025. Among urology clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $222.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$16K
- Medtronic$295
- Boston Scientific$291
- AbbVie$173
- Neotract Inc.$113
- Teleflex LLC$96
- plus $201 from 4 others
What the payments were for
- Consulting fees$11,92071%
- Speaking & faculty fees$6234%
- Travel & lodging$1,91511%
- Food & beverage$2,18813%
- Education$680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 49 | $15,545 |
| Medtronic(2 entities) | 2 | $295 |
| Boston Scientific | 8 | $291 |
| AbbVie(2 entities) | 3 | $173 |
| Neotract Inc. | 4 | $113 |
| Teleflex LLC | 5 | $96 |
| Johnson & Johnson | 1 | $68 |
| Rochester Medical Corporation | 1 | $54 |
| Convatec Inc. | 1 | $47 |
| Photocure Inc | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$14,279
- Axonics r-SNM System$581
- Bulkamid$326
- INTERSTIM$295
- BOTOX$126
How this compares
$16,714 in reported general payments places this provider in the 95th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 165 | $163,142 |
| GemtesaVibegron | 172 | $162,261 |
| Solifenacin Succinate | 246 | $15,945 |
| Tolterodine Tartrate ErTolterodine Tartrate | 165 | $13,987 |
| Mirabegron ErMirabegron | 18 | $13,043 |
| Desmopressin Acetate | 107 | $6,685 |
| Methenamine Hippurate | 61 | $6,332 |
| Oxybutynin Chloride ErOxybutynin Chloride | 269 | $5,025 |
| PremarinEstrogens, Conjugated | 11 | $4,720 |
| Trospium Chloride | 62 | $4,358 |
| Potassium Citrate ErPotassium Citrate | 37 | $2,990 |
| Trospium Chloride ErTrospium Chloride | 17 | $2,664 |
| Estradiol | 45 | $2,420 |
| Oxybutynin Chloride | 89 | $1,591 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 169 | $1,518 |
Paid to pharmacies, not to this prescriber.
Other urology in Portland
- David SobelPortland$58K
- Gabriel BelangerPortland$2K
- Gregory AdeyPortland$2K
- Benjamin ScollPortland$784
- Griffith BatstoneFarmington$123K
- Evan DunnLewiston$9K
- Robert FisherRockport$9K
- Christopher HenryLewiston$6K
- Jesse SammonSouth Portland$6K
- Sanchita BoseSouth Portland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.